Cogent Biosciences
Filed with the SEC on · accession 0001193125-26-342683
COGT filed a 424B5 (prospectus (offering)) with the SEC on Aug 10, 2026. The final terms of an offering of shares or bonds. The stock moved -2.0% by the first close after the filing.
Cogent Biosciences filed a prospectus supplement to offer up to $400,000,000 of its common stock in an at-the-market offering through Guggenheim Securities as agent.
Close before
$42.39
Aug 7, 2026
First close after
-2.03%
$41.53
5 trading days
-10.52%
$37.93
Since filing
-30.22%
$29.58
✦ Ask GOAX AI about this filing — what it means for COGT, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for COGT?
Click hereCOGT filed a 424B5 (Secondary offering). Cogent Biosciences filed a prospectus supplement to offer up to $400,000,000 of its common stock in an at-the-market offering through Guggenheim Securities as agent.
New shares dilute existing holders and are often sold at a discount to the market price.
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
COGT closed at $42.39 before the filing and $41.53 on Aug 10, 2026 (-2.03%). Five trading days later: $37.93 (-10.52%).
Get alerts when COGT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days